Hartford Financial Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54K | Hold |
28
| – | – | ﹤0.01% | 328 |
|
|
2025
Q1 | $1.98K | Hold |
28
| – | – | ﹤0.01% | 337 |
|
|
2024
Q4 | $1.84K | Hold |
28
| – | – | ﹤0.01% | 361 |
|
|
2024
Q3 | $1.97K | Hold |
28
| – | – | ﹤0.01% | 365 |
|
|
2024
Q2 | $2.31K | Hold |
28
| – | – | ﹤0.01% | 356 |
|
|
2024
Q1 | $2.45K | Hold |
28
| – | – | ﹤0.01% | 357 |
|
|
2023
Q4 | $2.7K | Hold |
28
| – | – | ﹤0.01% | 362 |
|
|
2023
Q3 | $2.48K | Buy |
28
+10
| +56% | +$885 | ﹤0.01% | 360 |
|
|
2023
Q2 | $1.56K | Hold |
18
| – | – | ﹤0.01% | 354 |
|
|
2023
Q1 | $1.75K | Buy |
+18
| New | +$1.75K | ﹤0.01% | 353 |
|
|
2017
Q4 | – | Sell |
-610
| Closed | -$56K | – | 343 |
|
|
2017
Q3 | $56K | Hold |
610
| – | – | 0.03% | 184 |
|
|
2017
Q2 | $55K | Hold |
610
| – | – | 0.02% | 186 |
|
|
2017
Q1 | $53K | Buy |
+610
| New | +$53K | 0.03% | 182 |
|